Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
The Procter & Gamble Company launched a preliminary prospectus supplement for a primary offering of euro‑denominated senior notes in two series. Interest will be paid annually in arrears starting in 2026, and the notes may be redeemed at P&G’s option at make‑whole prices, plus a tax redemption if certain U.S. tax events occur. The notes will be issued in registered form in minimum denominations of €100,000 and integral multiples of €1,000. Application will be made to list the notes on the New York Stock Exchange.
The offering will settle in book‑entry form through Clearstream and Euroclear. The supplement includes standard “additional amounts” provisions for non‑U.S. holders to address withholding, and outlines product governance and retail investor restrictions in the EEA and UK. P&G highlights macroeconomic, geopolitical, supply chain, cybersecurity and regulatory risks relevant to its global operations.
As context, for the quarter ended September 30, 2025, net sales were $22,386 million and net earnings attributable to P&G were $4,750 million, with diluted EPS of $1.95. As of September 30, 2025, total assets were $127,599 million, long‑term debt was $24,315 million and shareholders’ equity was $53,551 million.
The Procter & Gamble Company reported first‑quarter results for the three months ended September 30, 2025. Net sales were $22.4 billion, up 3% year over year, driven by 1% pricing, 1% mix and 1% favorable foreign exchange. Operating income was $5.9 billion (up 1%), while gross margin was 51.4% (down 70 bps) and operating margin was 26.2% (down 50 bps).
Net earnings rose 20% to $4.8 billion, and diluted EPS increased 21% to $1.95, reflecting the prior year’s Argentina-related charges. Operating cash flow was $5.4 billion; capital expenditures were $1.2 billion; adjusted free cash flow was $4.9 billion with 102% productivity. The company paid $2.55 billion in dividends and repurchased $1.25 billion of stock.
By segment, net sales grew in Beauty (+6%), Grooming (+5%), Health Care (+2%), Fabric & Home Care (+1%) and Baby, Feminine & Family Care (+1%). P&G incurred $215 million in restructuring charges as part of its two‑year $1.5–$2.0 billion productivity plan. The Glad joint venture will not be renewed; P&G expects about $500 million of proceeds and a $250–$300 million after‑tax gain in the third quarter of fiscal 2026. Shares outstanding were 2,336,733,549 as of September 30, 2025.
The Procter & Gamble Company furnished a Regulation FD update tied to its first-quarter results. On October 24, 2025, the company announced those results, hosted a conference call, and made a slide presentation available to investors. The materials are furnished under Item 7.01.
PG attached Exhibit 99.1, titled “Informational Slides Provided by The Procter & Gamble Company,” and included the Inline XBRL cover page file as Exhibit 104. The slides referenced on the call are also posted on the company’s website.
The Procter & Gamble Company furnished a Form 8-K under Item 2.02 to note it issued a news release regarding earnings for the quarter ended September 30, 2025.
The company attached the news release as Exhibit 99.1. The filing is presented as an informational update about recent operating results and financial condition.
The Procter & Gamble Company reported that shareholders approved the 2025 Stock and Incentive Compensation Plan, which authorizes awards covering up to 175,000,000 shares of common stock. The plan permits grants of stock, RSUs, PSUs, options, and SARs, and also allows use of any shares remaining available under the 2019 plan.
At the October 14, 2025 Annual Meeting, all director nominees were elected. Shareholders ratified the independent auditor, and the advisory Say on Pay vote was approved. A shareholder proposal requesting additional reporting on plastic packaging did not pass.
Procter & Gamble (PG) reported an insider transaction: Director Patricia A. Woertz acquired 31 shares of common stock on 10/14/2025 at $0, coded as an “A” transaction.
The filing notes these were Restricted Stock Units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, Woertz beneficially owns 51,548.5268 shares, held directly.
Procter & Gamble (PG) director Rajesh Subramaniam reported an acquisition of 1,475 shares of common stock on 10/14/2025 via a Form 4. The transaction was coded A (award) at a price of $0, reflecting a grant of Restricted Stock Units under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this award, Subramaniam beneficially owns 6,149.8264 shares directly. The total includes dividend equivalents granted in the form of Restricted Stock Units.
Procter & Gamble (PG) reported a director equity award. On 10/14/2025, Director Robert Portman acquired 1,475 shares of common stock at a price of $0, indicated as restricted stock units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
Following this grant, Portman beneficially owns 4,894.5944 shares, held directly. This filing reflects routine director compensation through equity and does not indicate any open‑market purchase or sale.
Procter & Gamble (PG) director Ashley McEvoy reported an equity award on Form 4. On 10/14/2025, she acquired 1,475 shares of common stock, transaction code “A,” at $0 per footnote, granted under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. After this award, she beneficially owns 5,318.0241 shares, held directly.
Procter & Gamble (PG) director Christine M. McCarthy reported acquiring 1,475 shares of common stock on 10/14/2025 at $0, reflecting Restricted Stock Units awarded under The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Following this transaction, she beneficially owned 16,421.5131 shares, held directly. The filing was made by one reporting person.